Genmab A (GMAB) Other financing activities (2023 - 2026)

Genmab A's Other financing activities history runs 4 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• Quarterly Other financing activities rose 100.0% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.0 million (down 46.94% YoY) and the FY2024 annual result came in at $19.0 million, down 9.52% from the prior year.
• Other financing activities was $2.0 million for Q1 2026 at Genmab A, down from $16.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $21.0 million in Q4 2023 and bottomed at $1.0 million in Q1 2025.
• A 4-year average of $11.6 million and a median of $11.0 million in 2024 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2025 — Other financing activities slumped 88.89% — and 2026, when it surged 100.0%.
• Genmab A's Other financing activities stood at $21.0 million in 2023, then decreased by 9.52% to $19.0 million in 2024, then declined by 15.79% to $16.0 million in 2025, then sank by 87.5% to $2.0 million in 2026.
• Business Quant data shows GMAB's Other financing activities at $2.0 million in Q1 2026, $16.0 million in Q3 2025, and $7.0 million in Q2 2025.